User Reviews for Teniposide

Also known as: Vumon

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Teniposide.

Condition	Reviews	Compare	Avg. Ratings
Acute Lymphoblastic Leukemia	0 reviews	13 medications	Not rated - Be the first
Acute Lymphocytic Leukemia	0 reviews	20 medications	Not rated - Be the first
Non-Hodgkin's Lymphoma	0 reviews	26 medications	Not rated - Be the first

Reviews for Teniposide

There are no reviews - Be the first

Related Teniposide Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Positive evidence of risk

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Mitotic inhibitors

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

More...

Get Updates by Email

Email me about teniposide systemic:

Related News and Articles

FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer 31 January 2012
The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive...
Inherited Risk Factors for Childhood Leukemia are More Common in Hispanic Patients 30 January 2012
Results from a St. Jude Children's Research Hospital and the Children's Oncology Group study pinpoint genetic basis for increased leukemia...
Cell Therapeutics Withdraws New Drug Application for Pixuvri and Plans to Resubmit in 2012 30 January 2012
Cell Therapeutics, Inc. ("CTI") announced today that it has voluntarily withdrawn its New Drug Application ("NDA") for Pixuvri (pixantrone) for the...
FDA's Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012 3 January 2012
Cell Therapeutics, Inc. (CTI) announced today that on February 9, 2012 the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee...
Micromet's Blinatumomab Produces High Rate of Durable Hematologic Complete Remissions in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia 12 December 2011
75% of patients who received the selected dose and schedule achieved a complete remission, with no detectable leukemic cells remaining Median survival not...

Help and Support

Looking for answers? Ask a question or go join the teniposide support group to connect with others who have similar interests.

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search:

User Reviews for Teniposide

Reviews for Teniposide

See also...

Related Teniposide Information